The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Adaptation of High-Throughput Screening in Drug Discovery—Toxicological Screening Tests
Open accessAbstract
High-throughput screening (HTS) is one of the newest techniques used in drug design and may be applied in biological and chemical sciences. This method, due to utilization of robots, detectors and software that regulate the whole process, enables a series of analyses of chemical compounds to be conducted in a short time and the affinity of biological structures which is often related to toxicity to be defined. Since 2008 we have implemented the automation of this technique and as a consequence, the possibility to examine 100,000 compounds per day. The HTS method is more frequently utilized in conjunction with analytical techniques such as NMR or coupled methods e.g., LC-MS/MS. Series of studies enable the establishment of the rate of affinity for targets or the level of toxicity. Moreover, researches are conducted concerning conjugation of nanoparticles with drugs and the determination of the toxicity of such structures. For these purposes there are frequently used cell lines. Due to the miniaturization of all systems, it is possible to examine the compound’s toxicity having only 1–3 mg of this compound. Determination of cytotoxicity in this way leads to a significant decrease in the expenditure and to a reduction in the length of the study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microscale culture of human liver cells for drug development
Khetani, S. R., & Bhatia, S. N. (2008) · Nature Biotechnology · doi:10.1038/nbt1361 · Cited by 1,219
The ToxCast Program for Prioritizing Toxicity Testing of Environmental Chemicals
Dix, D. J., Houck, K. A., Martin, M. T., Richard, A. M., Setzer, R. W., & Kavlock, R. J. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfl103 · Cited by 1,012
Debnath, A. K., Lopez de Compadre, R. L., Debnath, G., Shusterman, A. J., & Hansch, C. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00106a046 · Cited by 868
Kirkland, D., Aardema, M., Henderson, L., & Müller, L. (2005) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2005.02.004 · Cited by 754
Structure-based virtual screening: an overview
Lyne, P. D. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02483-2 · Cited by 662
O’Brien, P. J., Irwin, W., Diaz, D., Howard-Cofield, E., Krejsa, C. M., Slaughter, M. R., Gao, B., Kaludercic, N., Angeline, A., Bernardi, P., et al. (2006) · Archives of Toxicology · doi:10.1007/s00204-006-0091-3 · Cited by 609
T-Cell Signaling Regulated by the Tec Family Kinase, Itk
Andreotti, A. H., Schwartzberg, P. L., Joseph, R. E., & Berg, L. J. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a002287 · Cited by 593
Exploring the Mode-of-Action of Bioactive Compounds by Chemical-Genetic Profiling in Yeast
Parsons, A. B., Lopez, A., Givoni, I. E., Williams, D. E., Gray, C. A., Porter, J., Chua, G., Sopko, R., Brost, R. L., Ho, C.-H., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.040 · Cited by 515
Pursuing the leadlikeness concept in pharmaceutical research
Hann, M. M., & Oprea, T. I. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.04.003 · Cited by 515
Luo, G., Cunningham, M., Kim, S., Burn, T., Lin, J., Sinz, M., Hamilton, G., Rizzo, C., Jolley, S., Gilbert, D., et al. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.7.795 · Cited by 442
Microtiter Plate Assays for Inhibition of Human, Drug-Metabolizing Cytochromes P450
Crespi, C. L., Miller, V. P., & Penman, B. W. (1997) · Analytical Biochemistry · doi:10.1006/abio.1997.2145 · Cited by 406
Cellular imaging in drug discovery
Lang, P., Yeow, K., Nichols, A., & Scheer, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2008 · Cited by 351
Three-dimensional cellular microarray for high-throughput toxicology assays
Lee, M.-Y., Kumar, R. A., Sukumaran, S. M., Hogg, M. G., Clark, D. S., & Dordick, J. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708756105 · Cited by 314
MULTICASE 1. A Hierarchical Computer Automated Structure Evaluation Program
Klopman, G. (1992) · Quantitative Structure-Activity Relationships · doi:10.1002/qsar.19920110208 · Cited by 313
In silico toxicology for the pharmaceutical sciences☆
Valerio Jr., L. G. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.08.022 · Cited by 296
Identifying off-target effects and hidden phenotypes of drugs in human cells
MacDonald, M. L., Lamerdin, J., Owens, S., Keon, B. H., Bilter, G. K., Shang, Z., Huang, Z., Yu, H., Dias, J., Minami, T., et al. (2006) · Nature Chemical Biology · doi:10.1038/nchembio790 · Cited by 293
Shukla, S. J., Huang, R., Austin, C. P., & Xia, M. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.07.007 · Cited by 291
Fernandes, T. G., Diogo, M. M., Clark, D. S., Dordick, J. S., & Cabral, J. M. S. (2009) · Trends in Biotechnology · doi:10.1016/j.tibtech.2009.02.009 · Cited by 285
The Future of High-Throughput Screening
Mayr, L. M., & Fuerst, P. (2008) · SLAS Discovery · doi:10.1177/1087057108319644 · Cited by 276
High-Content Screening: A New Approach to Easing Key Bottlenecks in the Drug Discovery Process
Giuliano, K. A., DeBiasio, R. L., Dunlay, R. T., Gough, A., Volosky, J. M., Zock, J., Pavlakis, G. N., & Taylor, D. L. (1997) · SLAS Discovery · doi:10.1177/108705719700200410 · Cited by 229
Criscione, L., Rigollier, P., Batzl-Hartmann, C., Rüeger, H., Stricker-Krongrad, A., Wyss, P., Brunner, L., Whitebread, S., Yamaguchi, Y., Gerald, C., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4188 · Cited by 226
Mueller, H., Kassack, M. U., & Wiese, M. (2004) · SLAS Discovery · doi:10.1177/1087057104265386 · Cited by 226
Micro-bioreactor array for controlling cellular microenvironments
Figallo, E., Cannizzaro, C., Gerecht, S., Burdick, J. A., Langer, R., Elvassore, N., & Vunjak-Novakovic, G. (2007) · Lab on a Chip · doi:10.1039/b700063d · Cited by 220
In vivo RNAi: Today and Tomorrow
Perrimon, N., Ni, J.-Q., & Perkins, L. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003640 · Cited by 205
Kasibhatla, S., Gourdeau, H., Meerovitch, K., Drewe, J., Reddy, S., Qiu, L., Zhang, H., Bergeron, F., Bouffard, D., Yang, Q., et al. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1365.3.11 · Cited by 205
Looking forward to seeing calcium
Rudolf, R., Mongillo, M., Rizzuto, R., & Pozzan, T. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1153 · Cited by 203
Drug metabolism and pharmacokinetics
Benedetti, M. S., Whomsley, R., Poggesi, I., Cawello, W., Mathy, F.-X., Delporte, M.-L., Papeleu, P., & Watelet, J.-B. (2009) · Drug Metabolism Reviews · doi:10.1080/10837450902891295 · Cited by 201
Biological spectra analysis: Linking biological activity profiles to molecular structure
Fliri, A. F., Loging, W. T., Thadeio, P. F., & Volkmann, R. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407790101 · Cited by 190
The expanding role of quantitative structure-activity relationships (QSAR) in toxicology
Hansch, C., Hoekman, D., Leo, A., Zhang, L., & Li, P. (1995) · Toxicology Letters · doi:10.1016/0378-4274(95)03356-p · Cited by 188
Computational Toxicology—A State of the Science Mini Review
Kavlock, R. J., Ankley, G., Blancato, J., Breen, M., Conolly, R., Dix, D., Houck, K., Hubal, E., Judson, R., Rabinowitz, J., et al. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfm297 · Cited by 181
High-throughput process development for biopharmaceutical drug substances
Bhambure, R., Kumar, K., & Rathore, A. S. (2011) · Trends in Biotechnology · doi:10.1016/j.tibtech.2010.12.001 · Cited by 177
High-throughput drug discovery: What can we expect from HTS?
Gribbon, P., & Andreas, S. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03275-1 · Cited by 174
Neurotoxicity assessment using zebrafish
Parng, C., Roy, N. M., Ton, C., Lin, Y., & McGrath, P. (2007) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2006.04.004 · Cited by 169
Shibata, Y., Takahashi, H., Chiba, M., & Ishii, Y. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.8.892 · Cited by 167
Lee, M.-Y., Park, C. B., Dordick, J. S., & Clark, D. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406755102 · Cited by 163
Ion-channel assay technologies: quo vadis?
Xu, J., Wang, X., Ensign, B., Li, M., Wu, L., Guia, A., & Xu, J. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)02095-5 · Cited by 161
Assessment of the performance of the Ames II™ assay: a collaborative study with 19 coded compounds
Flückiger‐Isler, S., Baumeister, M., Braun, K., Gervais, V., Hasler-Nguyen, N., Reimann, R., Gompel, J. V., Wunderlich, H. G., & Engelhardt, G. (2004) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2003.12.001 · Cited by 159
Algorithms for network analysis in systems-ADME/Tox using the MetaCore and MetaDrug platforms
Ekins, S., Bugrim, A. E., Brovold, L., Kirillov, E., Nikolsky, Y., Rakhmatulin, E. A., Sorokina, S. Y., Ryabov, A., Serebryiskaya, T., Melnikov, A., et al. (2006) · Xenobiotica · doi:10.1080/00498250600861660 · Cited by 156
Matthews, E. J., & Contrera, J. F. (1998) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.1998.1259 · Cited by 142
Detection and Characterizationof Cellular Immune Responses Using Peptide–MHC Microarrays
Soen, Y., Chen, D. S., Kraft, D. L., Davis, M. M., & Brown, P. O. (2003) · PLoS Biology · doi:10.1371/journal.pbio.0000065 · Cited by 142
Bailey, S. N., Sabatini, D. M., & Stockwell, B. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404425101 · Cited by 136
Lau, Y. Y., Sapidou, E., Cui, X., White, R. E., & Cheng, K.-C. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.12.1446 · Cited by 131
Li, A. P., Bode, C., & Sakai, Y. (2004) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2004.09.010 · Cited by 112
Understanding mechanisms of toxicity: Insights from drug discovery research
Houck, K. A., & Kavlock, R. J. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.10.022 · Cited by 112
Arrays for the Combinatorial Exploration of Cell Adhesion
Orner, B. P., Derda, R., Lewis, R. L., Thomson, J. A., & Kiessling, L. L. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0474291 · Cited by 112
Helma, C. (2006) · Molecular Diversity · doi:10.1007/s11030-005-9001-5 · Cited by 110
Nichols, J. S., Parks, D. J., Consler, T. G., & Blanchard, S. G. (1998) · Analytical Biochemistry · doi:10.1006/abio.1997.2557 · Cited by 109
Genetic toxicology in the 21st century: Reflections and future directions
Mahadevan, B., Snyder, R. D., Waters, M. D., Benz, R. D., Kemper, R. A., Tice, R. R., & Richard, A. M. (2011) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20653 · Cited by 106
From alternative methods to a new toxicology
Härtung, T. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.12.027 · Cited by 102
Micro-stamped surfaces for the patterned growth of neural stem cells
Ruiz, A., Bużańska, L., Gilliland, D. D., Rauscher, H., Sirghi, L., Sobański, T., Zychowicz, M., Ceriotti, L., Brétagnol, F., Coecke, S., et al. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.08.017 · Cited by 99
Application of High-Throughput, Molecular-Targeted Screening to Anticancer Drug Discovery
Shoemaker, R., Scudiero, D. A., Melillo, G., Currens, M. J., Monks, A. P., Rabow, A. A., Covell, D. G., & Sausville, E. A. (2002) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026023394317 · Cited by 98
Contrera, J. F., Matthews, E. J., & Benz, R. D. (2003) · Regulatory Toxicology and Pharmacology · doi:10.1016/s0273-2300(03)00071-0 · Cited by 93
Trubetskoy, O. V., Gibson, J. R., & Marks, B. D. (2005) · SLAS DISCOVERY · doi:10.1177/1087057104269731 · Cited by 89
Virtual high-throughput in silico screening
Seifert, M. H. J., Wolf, K., & Vitt, D. (2003) · BIOSILICO · doi:10.1016/s1478-5382(03)02359-x · Cited by 81
Molecular and functional analysis using live cell microarrays
Chen, D. S., & Davis, M. M. (2006) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2006.01.001 · Cited by 79
The Challenge of Predicting Drug Toxicityin silico
Vedani, A., Dobler, M., & Lill, M. A. (2006) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2006.pto_471.x · Cited by 74
Fairn, G. D., MacDonald, K., & McMaster, C. R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m610575200 · Cited by 70
High-Throughput Screening: The Hits and Leads of Drug Discovery- An Overview
Martis, E. A. F., & Radhakrishnan (2011) · Cited by 70
High content cellular screening
Rausch, O. (2006) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2006.06.004 · Cited by 69
Live Cell Quality Control and Utility of Real-Time Cell Electronic Sensing for Assay Development
Kirstein, S. L., Atienza, J. M., Xi, B., Zhu, J., Yu, N., Wang, X., Xu, X. Y., & Abassi, Y. A. (2006) · Assay and Drug Development Technologies · doi:10.1089/adt.2006.4.545 · Cited by 67
Characterization of compound mechanisms and secondary activities by BioMAP analysis
Berg, E. L., Kunkel, E. J., Hytopoulos, E., & Plavec, I. (2005) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2005.06.003 · Cited by 63
A Homogeneous in Vitro Functional Assay for Estrogen Receptors: Coactivator Recruitment
Liu, J., Knappenberger, K. S., Käck, H., Andersson, G., Nilsson, E., Dartsch, C., & Scott, C. W. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0331 · Cited by 63
Integration of NMR and High-Throughput Screening
Hajduk, P. J., & Burns, D. J. (2002) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207023329996 · Cited by 63
Future of ToxicologyPredictive Toxicology: An Expanded View of “Chemical Toxicity”
Richard, A. M. (2006) · Chemical Research in Toxicology · doi:10.1021/tx060116u · Cited by 61
Della‐Zuana, O., Sadlo, M., Germain, M., Félétou, M., Chamorro, S., Tisserand, F., de Montrion, C., Boivin, J.-F., Duhault, J., Boutin, J. A., et al. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801472 · Cited by 60
Brandish, P. E., Chiu, C., Schneeweis, J. E., Brandon, N. J., Leech, C. L., Kornienko, O., Scolnick, E. M., Strulovici, B., & Zheng, W. (2006) · SLAS DISCOVERY · doi:10.1177/1087057106288181 · Cited by 59
Ozers, M. S., Ervin, K. M., Steffen, C. L., Fronczak, J. A., Lebakken, C. S., Carnahan, K. A., Lowery, R. G., & Burke, T. J. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0256 · Cited by 59
The computational prediction of toxicity
Barratt, M. D., & Rodford, R. (2001) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(00)00218-0 · Cited by 49
Biomaterials science and high-throughput screening
Hubbell, J. A. (2004) · Nature Biotechnology · doi:10.1038/nbt0704-828 · Cited by 48
Ritter, D. G., & Knebel, J. (2009) · Toxicology in Vitro · doi:10.1016/j.tiv.2009.07.007 · Cited by 46
Bringing toxicology into the 21st century: A global call to action
Seidle, T., & Stephens, M. L. (2009) · Toxicology in Vitro · doi:10.1016/j.tiv.2009.06.012 · Cited by 44
Ekins, S. (2006) · Wiley eBooks · doi:10.1002/9780470145890 · Cited by 44
The Drug Discovery Portal: a resource to enhance drug discovery from academia
Clark, R. L., Johnston, B. F., Mackay, S. P., Breslin, C. J., Robertson, M. N., & Harvey, A. L. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.06.003 · Cited by 42
Lewis, D. F. (2001) · Journal of Chemical Technology & Biotechnology · doi:10.1002/jctb.363 · Cited by 41
Voltage-Gated Ion Channels as Drug Targets
(2006) · Methods and principles in medicinal chemistry · doi:10.1002/3527608141 · Cited by 41
Murphy, S. M., Palmer, M., Poole, M. F., Padegimas, L., Hunady, K., Danzig, J., Gill, S. S., Gill, R. K., Ting, A. E., Sherf, B. A., et al. (2005) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2005.10.003 · Cited by 39
The zebrafish as a novel system for functional genomics and therapeutic development applications.
Nasevicius, A., & Ekker, S. C. (2001) · PubMed · Cited by 39
Current trends in modern pharmaceutical analysis for drug discovery
Koh, H., Yau, W., Ong, P.-S., & Hegde, A. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02846-0 · Cited by 38
Integration of virtual and physical screening
Fara, D. C., Oprea, T. I., Prossnitz, E. R., Bologa, C., Edwards, B. S., & Sklar, L. A. (2006) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2006.11.003 · Cited by 36
Chin, J., Adams, A. D., Bouffard, A., Green, A., Lacson, R., Smith, T., Fischer, P. A., Menke, J. G., Sparrow, C. P., & Mitnaul, L. J. (2003) · Assay and Drug Development Technologies · doi:10.1089/154065803772613417 · Cited by 33
Application of data mining approaches to drug delivery
Ekins, S., Shimada, J., & Chang, C. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.005 · Cited by 31
Combinatorial biomarkers: From early toxicology assays to patient population profiling
Koop, R. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03440-9 · Cited by 30
Development of a Versatile Platform for Nuclear Receptor Screening Using AlphaScreen™
Rouleau, N., Turcotte, S., Mondou, M.-H., Roby, P., & Bossé, R. (2003) · SLAS DISCOVERY · doi:10.1177/1087057103252605 · Cited by 28
Bernauer, U., Glatt, H. R., Heinrich-Hirsch, B., Liu, Y., Muckel, E., Vieth, B., & Gundert‐Remy, U. (2003) · Alternatives to Laboratory Animals · doi:10.1177/026119290303100104 · Cited by 18
Glover, C. J., Rabow, A. A., İşgör, Y. G., Shoemaker, R. H., & Covell, D. G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.10.005 · Cited by 16
Microarraying the cellular microenvironment
Jang, J., & Schaffer, D. V. (2006) · Molecular Systems Biology · doi:10.1038/msb4100079 · Cited by 12
Cheng, K.-C., Li, C., Hsieh, Y., Montgomery, D. L., Liu, T., & White, R. E. (2005) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2005.08.002 · Cited by 10
Giddings, S. J., Clarke, S. E., & Gibson, G. G. (1997) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03190963 · Cited by 7
Future of Computational Toxicology: Broad Application into Human Disease and Therapeutics
Johnson, D. E., Rodgers, A. D., & Sudarsanam, S. (2006) · Computational Toxicology · doi:10.1002/9780470145890.ch26 · Cited by 6
The use of human cell line reporter gene-based assays in chemical toxicity testing
Scrivens, M., & Bhogal, N. (2007) · Toxicology in Vitro · doi:10.1016/j.tiv.2007.05.006 · Cited by 6
Research works printed but not linked: 35
- Armstrong, 1999, A review of high-throughput screening approaches for drug discovery, Am. Biotechnol. Lab, 17, 26
- How, 2004, Polyplexes and lipoplexes for mammalian gene delivery: From traditional to microarray screening, Comb. Chem. High Throughput Screen, 7, 423, 10.2174/1386207043328616 · doi:10.2174/1386207043328616
- Cotgreave, 2011, How can stem cell technologies be applied to replace animal use in toxicity testing, Toxicol. Lett, 205, S29, 10.1016/j.toxlet.2011.05.116 · doi:10.1016/j.toxlet.2011.05.116
- Salem, H., and Katz, S.A. (1998). Advances in Animal Alternatives for Safety and Efficacy Testing, Taylor & Francis. · doi:10.1201/9781439805817
- Lewis, 1993, Validation of a novel molecular orbital approach (COMPACT) for the prospective safety evaluation of chemicals, by comparison with rodent carcinogenicity and the Salmonella mutagenicity data evaluated by the U.S. NCI/NTP, Mutat. Res, 291, 61, 10.1016/0165-1161(93)90018-U · doi:10.1016/0165-1161(93)90018-u
- Hemla, C. (2005). Predictive Toxicology, CRC Press. · doi:10.1201/9780849350351
- Okada, 2003, Characteristic substructures and properties in chemical carcinogens studied by the cascade model, Bioinformatics, 19, 1208, 10.1093/bioinformatics/btg129 · doi:10.1093/bioinformatics/btg129
- Judson, P.N. (2006). Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley.
- Smithing, 1992, HazardExpert. An expert system for predicting chemical toxicity, ACS Symp. Ser, 484, 191, 10.1021/bk-1992-0484.ch019 · doi:10.1021/bk-1992-0484.ch019
- Lee, 2005, Metabolizing enzyme toxicology assay chip (MetaChip) for high-throughput microscale toxicity analyses, Proc. Natl. Acad. Sci. USA, 102, 983, 10.1073/pnas.0406755102 · DOI · Paper page
- Cui, 2005, Quantitative PCR assay for cytochromes P450 2B and 3A induction in rat precision-cut liver slices: Correlation study with induction in vivo, J. Pharmacol. Toxicol. Methods, 53, 215
- Corona, 2004, High throughput screening of genetic polymorphisms by matrix-assisted laser desorption ionization time-of-flight mass spectrometry, Comb. Chem. High Throughput Screen, 7, 707, 10.2174/1386207043328283 · doi:10.2174/1386207043328283
- Marks, 2003, High-throughput screening Assays for CYP2B6 Metabolism and Inhibition, AAPS PharmSci, 5, 1, 10.1208/ps050218 · doi:10.1208/ps050218
- Evans, 2010, Mutant cells defective in DNA repair pathways provide a sensitive high-throughput assay for genotoxicity, DNA Repair, 9, 1292, 10.1016/j.dnarep.2010.09.017 · doi:10.1016/j.dnarep.2010.09.017
- Miller, 2005, A low volume, high-throughput forward mutation assay in Salmonella typhimurium based on fluorouracil resistance, Mutat. Res, 578, 210, 10.1016/j.mrfmmm.2005.05.023 · doi:10.1016/j.mrfmmm.2005.05.023
- Comley, 2005, Automated patch clamping setting a new standard for early hERG, Drug Discov. World, 6, 62
- Molokanova, 2008, Bright future of optical assays for ion channel drug discovery, Drug Discov. Today, 13, 14, 10.1016/j.drudis.2007.11.009 · DOI
- Mattheakis, 2001, Assay technologies for screening ion channel targets, Curr. Opin. Drug Discov. Devel, 1, 124
- Finlayson, 2001, [3H]dofetilide binding to HERG transfected membranes: A potential high throughput preclinical screen, Eur. J. Pharmacol, 430, 147, 10.1016/S0014-2999(01)01362-0 · doi:10.1016/s0014-2999(01)01362-0
- Cheng, 2002, A high-throughput HERG potassium channel function assay: An old assay with a new look, Drug Dev. Ind. Pharm, 28, 177, 10.1081/DDC-120002451 · doi:10.1081/ddc-120002451
- Rueeger, 2004, Discovery and SAR of potent, orally available and brain-penetrable 5,6-dihydro-4H-3-thia-1-aza-benzo[e]azulenand 4,5-dihydro-6-oxa-1-aza-benzo[e]azulenderivatives as neuropeptide Y Y5 receptor antagonists, Bioorg. Med. Chem. Lett, 14, 2451, 10.1016/j.bmcl.2004.03.014 · doi:10.1016/j.bmcl.2004.03.014
- Anderson, 2004, Assessing behavioral toxicity with Caenorhabditis elegans, Environ. Toxicol. Chem, 23, 1235, 10.1897/03-264 · doi:10.1897/03-264
- Zhang, C., Willett, C., and Fremgen, T. (2003). Current Protocols in Toxicology, John Wiley & Sons.
- Lee, 2005, Metabolizing enzyme toxicology assay chip (MetaChip) for high-throughput microscale toxicity analyses, Proc. Natl. Acad. Sci. USA, 102, 983, 10.1073/pnas.0406755102 · DOI · Paper page
- Liao, 2005, Caenorhabditis elegans gcs-1 confers resistance to arsenic-induced oxidative stress, Biometals, 18, 519, 10.1007/s10534-005-2996-3 · doi:10.1007/s10534-005-2996-3
- Pulak, 2006, Techniques for analysis, sorting, and dispensing of C. elegans on the COPAS flow-sorting system, Methods Mol. Biol, 351, 275
- Haendel, 2005, Developmental toxicity of the dithiocarbamate pesticide sodium metam in zebrafish, Toxicol. Sci, 81, 390, 10.1093/toxsci/kfh202 · doi:10.1093/toxsci/kfh202
- Baranowski, T., Hesley, J., Cromwell, E., and Gedraitis, P.R. (2011). Novel imaging and analysis of zebrafish for high throughput screening. J. Pharmacol. Toxicol. Methods, 64. · doi:10.1016/j.vascn.2011.03.185
- Kumar, 2006, High-throughput screening of biocatalytic activity: Applications in drug discovery, Curr. Opin. Chem. Biol, 10, 162, 10.1016/j.cbpa.2006.02.033 · doi:10.1016/j.cbpa.2006.02.033
- Wang, 1998, A new ultra-high throughput method for characterizing combinatorial libraries incorporating a multiple probe autosampler coupled with flow injection mass spectrometry analysis, Rapid Commun. Mass Spectrom, 12, 1123, 10.1002/(SICI)1097-0231(19980831)12:16<1123::AID-RCM293>3.0.CO;2-W · doi:10.1002/(sici)1097-0231(19980831)12:16<1123::aid-rcm293>3.0.co;2-w
- Tutko, 1998, Sequential mass spectrometry and MSn analysis of combinatorial libraries by using automated matrix-assisted laser desorption/ionization Fourier transform mass spectrometry, Rapid Commun. Mass Spectrom, 12, 335, 10.1002/(SICI)1097-0231(19980331)12:6<335::AID-RCM160>3.0.CO;2-T · doi:10.1002/(sici)1097-0231(19980331)12:6<335::aid-rcm160>3.0.co;2-t
- Ermer, 2000, Applications of hyphenated LC-MS techniques in pharmaceutical analysis, Biomed. Chromatogr, 14, 373, 10.1002/1099-0801(200010)14:6<373::AID-BMC29>3.0.CO;2-S · doi:10.1002/1099-0801(200010)14:6<373::aid-bmc29>3.0.co;2-s
- Hughes, 2001, Techniques for analysis and purification in high-throughput chemistry, Curr. Opin. Chem. Biol, 5, 243, 10.1016/S1367-5931(00)00198-8 · doi:10.1016/s1367-5931(00)00198-8
- Kyranos, 2001, High-throughput techniques for compound characterization and purification, Curr. Opin. Drug Discov. Dev, 4, 719
- Weber, 2002, Multi-component reactions and evolutionary chemistry, Drug Discov. Today, 7, 143, 10.1016/S1359-6446(01)02090-6 · doi:10.1016/s1359-6446(01)02090-6
Cited by
Janssen, E. M.-L. (2019) · Water Research · doi:10.1016/j.watres.2018.12.048 · Cited by 386
Zhu, H., Zhang, J., Kim, M. T., Boison, A., Sedykh, A., & Moran, K. (2014) · Chemical Research in Toxicology · doi:10.1021/tx500145h · Cited by 154
Comparing Multiple Machine Learning Algorithms and Metrics for Estrogen Receptor Binding Prediction
Russo, D. P., Zorn, K. M., Clark, A. M., Zhu, H., & Ekins, S. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00546 · Cited by 152
Kempa, E. E., Smith, C. A., Li, X., Bellina, B., Richardson, K., Pringle, S., Galman, J. L., Turner, N. J., & Barran, P. E. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c02632 · Cited by 72
Protein‐protein interactions as antibiotic targets: A medicinal chemistry perspective
Cossar, P. J., Lewis, P. J., & McCluskey, A. (2020) · Medicinal Research Reviews · doi:10.1002/med.21519 · Cited by 55
Metadata
- Authors
- Szymański, P., Markowicz, M., & Mikiciuk-Olasik, E.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2011-12-29
- Volume
- 13
- Issue
- 1
- Pages
- 427-452
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W1971375063
- Cited by
- 454
- References
- 90
- FWCI
- 4.90
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.